In Reply Dr van den Berg-Wolf writes about the Ensuring Patient Access and Effective Drug Enforcement Act of 2016, which makes it more difficult for the DEA to suspend registration of manufacturers, distributors, retailers, and prescribers when evidence suggests they are involved in drug diversion. We agree that, in the midst of an addiction epidemic fueled in large part by prescription opioids, the DEA’s ability to regulate distribution of legal narcotics should not be hindered.
Kolodny A, Frieden TR. Government Actions to Curb the Opioid Epidemic—Reply. JAMA. 2018;319(15):1620–1621. doi:10.1001/jama.2018.0745
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: